REMS a cross departmental challenge for drugmakers says PPD
b'The US FDA\\u2019s risk evaluation mitigation strategy (REMS) can be a challenge for pharmaceutical companies unfamiliar with the process according to PPD\\u2019s executive director of risk management Frank Gallo.'